Literature DB >> 8447552

Relief of sickle cell priapism by hydralazine. Report of a case.

S Baruchel1, J Rees, M L Bernstein, P Goodyer.   

Abstract

We report a 16-year-old Tanner IV male with homozygous hemoglobin S who presented with recurrent episodes of priapism unresponsive to standard therapy with hydration, analgesia, and exchange transfusion. He had a complete resolution of his symptoms with hydralazine therapy. We therefore suggest a trial of vasodilator therapy for recurrent sickle cell priapism before attempting surgical therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8447552     DOI: 10.1097/00043426-199302000-00017

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  2 in total

Review 1.  Contemporary best practice in the evaluation and management of stuttering priapism.

Authors:  Georgios Kousournas; Asif Muneer; David Ralph; Evangelos Zacharakis
Journal:  Ther Adv Urol       Date:  2017-07-04

Review 2.  Priapism in hematological and coagulative disorders: an update.

Authors:  Belinda F Morrison; Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2011-03-15       Impact factor: 14.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.